AMRI 4Q Revenues: $86.6 million (+29%) 4Q Loss: $1.9 million (earnings were $4.3 million 4Q13) FY Revenues: $276.6 million (+12%) FY Loss: $3.3 million (earnings were $11.8 million FY13) Comments: Contract revenue for the quarter was $80.7 million, an increase of 35% driven by the Drug Product business, increased capacity utilization, and cost reduction initiatives and facility optimization. Royalty revenue in the quarter was $5.9 million, down 21%, which include $3.4 million in royalties f...